Evaluation of the Cytotoxic Effect of Hydroxypyridinone Derivatives on HCT116 and SW480 Colon Cancer Cell Lines


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

According to the literature, iron chelators have been used to inhibit tumor cell proliferation. Hydroxypyridinones, due to easy derivatization and high affinity for iron, have been suggested as an attractive target for the development of iron scavenging ligands. N-arylhydroxypyridinone derivatives as iron chelators have been previously designed and synthesized, and the present study is performed in order to evaluate the antitumor efficacy of these compounds,. Four derivatives of hydroxypyridinone were tested against HCT116 and SW480 colon cancer cell lines for 48 h using MTT assay. One compound (3-hydroxy-2-methyl-1-phenylpyridin-4(1H)-one, PMPO) showed the maximum cytotoxic activity on both HCT116 and SW480 cancer cells with IC50 = 243 and 180 μmol, respectively, for 48 h treatment. The obtained results demonstrated that various concentrations of test compounds exhibited significant reduction of the cell viability (P < 0.05) in a concentration dependent manner. Our findings indicate that the proposed hydroxypyridinone derivatives can be considered as a new option for the treatment of colon cancer.

Авторлар туралы

Hojjat Sadeghi-Aliabadi

Department of Medicinal Chemistry, Faculty of Pharmacy, Isfahan University of Medical Sciences

Хат алмасуға жауапты Автор.
Email: Sadeghi@pharm.mui.ac.ir
Иран, Isfahan, 81746-73461

Mohammad Zanjanchi

Department of Chemistry, Faculty of Science, University of Guilan

Email: Sadeghi@pharm.mui.ac.ir
Иран, Rasht, 41335 – 1914

Lotfollah Saghaie

Department of Medicinal Chemistry, Faculty of Pharmacy, Isfahan University of Medical Sciences

Email: Sadeghi@pharm.mui.ac.ir
Иран, Isfahan, 81746-73461

Mohammad Borzoei

Department of Medicinal Chemistry, Faculty of Pharmacy, Isfahan University of Medical Sciences; Department of Chemistry, Faculty of Science, University of Guilan; Infectious and Tropical Diseases Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences

Email: Sadeghi@pharm.mui.ac.ir
Иран, Isfahan, 81746-73461; Rasht, 41335 – 1914; Bandar Abbas


© Springer Science+Business Media, LLC, part of Springer Nature, 2019

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>